Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Differential CpG methylation of the promoter of interleukin 8 and the first intron of tissue factor in Antiphospholipid syndrome.

Patsouras MD, Karagianni P, Kogionou P, Vlachoyiannopoulos PG.

J Autoimmun. 2019 May 15. pii: S0896-8411(19)30124-6. doi: 10.1016/j.jaut.2019.05.001. [Epub ahead of print]

PMID:
31103268
2.

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network.

Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9.

PMID:
30967395
3.

Pseudochylothorax in a Patient with Rheumatoid Arthritis.

Kampolis CF, Vlachoyiannopoulos PG.

J Rheumatol. 2019 Feb;46(2):213-214. doi: 10.3899/jrheum.180251. No abstract available.

PMID:
30710002
4.

Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.

Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.

Clin Rheumatol. 2019 Jan;38(1):125-132. doi: 10.1007/s10067-018-4267-z. Epub 2018 Aug 25.

PMID:
30145635
5.

Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study.

Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG.

Clin Rheumatol. 2018 Mar;37(3):737-747. doi: 10.1007/s10067-017-3835-y. Epub 2017 Sep 15.

PMID:
28914375
6.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
7.

Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis.

Kalisperati P, Spanou E, Pateras IS, Korkolopoulou P, Varvarigou A, Karavokyros I, Gorgoulis VG, Vlachoyiannopoulos PG, Sougioultzis S.

Front Genet. 2017 Feb 27;8:20. doi: 10.3389/fgene.2017.00020. eCollection 2017. Review.

8.

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.

Sfikakis PP, Bournia VK, Sidiropoulos P, Boumpas DT, Drosos AA, Kitas GD, Konstantonis G, Liossis SN, Manoussakis MN, Sakkas L, Tektonidou M, Tzioufas AG, Vlachoyiannopoulos PG, Kani C, Paterakis P, Litsa P, Vassilopoulos D.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):579-585. Epub 2017 Mar 3.

PMID:
28281458
9.

Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study.

Lampropoulos CE, Orfanos P, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):192-200. Epub 2017 Jan 16.

PMID:
28094760
10.

Update of EULAR recommendations for the treatment of systemic sclerosis.

Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors.

Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.

PMID:
27941129
11.

Osteoporosis and vascular calcification in postmenopausal women: a cross-sectional study.

Lampropoulos CE, Kalamara P, Konsta M, Papaioannou I, Papadima E, Antoniou Z, Andrianopoulou A, Vlachoyiannopoulos PG.

Climacteric. 2016 Jun;19(3):303-7. doi: 10.3109/13697137.2016.1164134. Epub 2016 Apr 5.

PMID:
27045323
12.

Treatment of rheumatoid arthritis: Unraveling the conundrum.

Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG.

J Autoimmun. 2015 Dec;65:1-18. doi: 10.1016/j.jaut.2015.10.003. Epub 2015 Oct 27. Review.

PMID:
26515757
13.

Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.

Patsouras MD, Sikara MP, Grika EP, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG.

J Autoimmun. 2015 Dec;65:30-7. doi: 10.1016/j.jaut.2015.08.001. Epub 2015 Aug 15.

PMID:
26283469
14.

Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study.

Lampropoulos CE, Orfanos P, Bournia VK, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):216-24. Epub 2015 Feb 9.

PMID:
25664400
15.

Intact calibers of retinal vessels in patients with systemic sclerosis.

Aissopou EK, Bournia VK, Protogerou AD, Panopoulos S, Papaioannou TG, Vlachoyiannopoulos PG, Matucci-Cerinic M, Sfikakis PP.

J Rheumatol. 2015 Apr;42(4):608-13. doi: 10.3899/jrheum.141425. Epub 2015 Feb 1.

PMID:
25641886
16.

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.

Hachulla E, Clerson P, Airò P, Cuomo G, Allanore Y, Caramaschi P, Rosato E, Carreira PE, Riccieri V, Sarraco M, Denton CP, Riemekasten G, Pozzi MR, Zeni S, Mihai CM, Ullman S, Distler O, Rednic S, Smith V, Walker UA, Matucci-Cerinic M, Müller-Ladner U, Launay D; EUSTAR co-workers.

Rheumatology (Oxford). 2015 Jul;54(7):1262-9. doi: 10.1093/rheumatology/keu450. Epub 2015 Jan 17.

17.

Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study.

Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, Moutsopoulos HM, Tzioufas AG, Dalakas MC.

J Neurol Sci. 2014 Dec 15;347(1-2):143-7. doi: 10.1016/j.jns.2014.09.035. Epub 2014 Sep 28.

PMID:
25304055
18.

Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.

Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE, Caramaschi P, Ananieva LP, Matucci-Cerinic M, Czirjak L, Denton C, Ladner UM, Allanore Y; EUSTAR collaborators*; EUSTAR collaborators.

Ann Rheum Dis. 2016 Jan;75(1):103-9. doi: 10.1136/annrheumdis-2014-205295. Epub 2014 Aug 27.

PMID:
25165035
19.

Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.

Hudson M, Baron M, Tatibouet S, Furst DE, Khanna D; International Scleroderma Renal Crisis Study Investigators.

Semin Arthritis Rheum. 2014 Apr;43(5):666-72. doi: 10.1016/j.semarthrit.2013.09.008. Epub 2013 Oct 7.

PMID:
24176729
20.

Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.

Kampolis C, Tektonidou M, Moyssakis I, Tzelepis GE, Moutsopoulos H, Vlachoyiannopoulos PG.

Semin Arthritis Rheum. 2014 Feb;43(4):558-65. doi: 10.1016/j.semarthrit.2013.07.016. Epub 2013 Sep 5.

PMID:
24012042
21.

Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation.

Kosmas C, Papachrysanthou T, Daladimos T, Athanasopoulos A, Tsavaris N, Vlachoyiannopoulos PG.

Future Oncol. 2013 Sep;9(9):1401-6. doi: 10.2217/fon.13.70.

PMID:
23980687
22.

Psychological characteristics of systemic sclerosis patients and their correlation with major organ involvement and disease activity.

Golemati CV, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):37-45. Epub 2013 Jul 22.

PMID:
23910608
23.

Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients.

Kampylafka EI, Alexopoulos H, Kosmidis ML, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, Moutsopoulos HM, Tzioufas AG.

PLoS One. 2013;8(2):e55843. doi: 10.1371/journal.pone.0055843. Epub 2013 Feb 12.

24.

Dr. Vlachoyiannopoulos replies.

Vlachoyiannopoulos PG.

J Rheumatol. 2013 Jan;40(1):90. No abstract available.

PMID:
23401875
25.

Anticentromere (ACA)-positive Sjӧgren's syndrome: a disease entity?

Vlachoyiannopoulos PG, Moutsopoulos HM.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):163-4. Epub 2013 Jan 23. No abstract available.

PMID:
23343831
26.

Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis.

Giannakopoulos B, Gao L, Qi M, Wong JW, Yu DM, Vlachoyiannopoulos PG, Moutsopoulos HM, Atsumi T, Koike T, Hogg P, Qi JC, Krilis SA.

J Autoimmun. 2012 Sep;39(3):121-9. doi: 10.1016/j.jaut.2012.05.005. Epub 2012 Jun 13.

PMID:
22704541
27.

Subgroups of Sjögren syndrome patients according to serological profiles.

Bournia VK, Vlachoyiannopoulos PG.

J Autoimmun. 2012 Aug;39(1-2):15-26. doi: 10.1016/j.jaut.2012.03.001. Epub 2012 May 8. Review.

PMID:
22575069
28.

Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects.

Tzioufas AG, Vlachoyiannopoulos PG.

J Autoimmun. 2012 Aug;39(1-2):1-3. doi: 10.1016/j.jaut.2012.01.006. Epub 2012 Feb 21.

PMID:
22361268
29.

Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome.

Grika EP, Ziakas PD, Zintzaras E, Moutsopoulos HM, Vlachoyiannopoulos PG.

J Rheumatol. 2012 Mar;39(3):516-23. doi: 10.3899/jrheum.110800. Epub 2012 Jan 15.

PMID:
22247356
30.

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.

Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, Yu DM, Lau H, Sturgess AD, Vlachoyiannopoulos PG, Moutsopoulos HM, Rahman A, Pericleous C, Atsumi T, Koike T, Heritier S, Giannakopoulos B, Krilis SA.

Arthritis Rheum. 2011 Sep;63(9):2774-82. doi: 10.1002/art.30383.

31.

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.

Danielides S, Mavragani CP, Katsakoulas I, Zintzaras E, Drosos AA, Vlachoyiannopoulos PG, Moutsopoulos HM.

Scand J Rheumatol. 2011;40(4):299-303. doi: 10.3109/03009742.2010.549837. Epub 2011 Mar 21.

PMID:
21417550
32.

A novel mechanism of thrombosis in antiphospholipid antibody syndrome.

Vlachoyiannopoulos PG, Routsias JG.

J Autoimmun. 2010 Nov;35(3):248-55. doi: 10.1016/j.jaut.2010.06.015. Epub 2010 Jul 16. Review.

PMID:
20638238
33.

Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.

Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM.

Arthritis Res Ther. 2010;12(2):R47. doi: 10.1186/ar2958. Epub 2010 Mar 13.

34.

{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.

Sikara MP, Routsias JG, Samiotaki M, Panayotou G, Moutsopoulos HM, Vlachoyiannopoulos PG.

Blood. 2010 Jan 21;115(3):713-23. doi: 10.1182/blood-2009-03-206367. Epub 2009 Oct 5.

35.

Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations.

Mavragani CP, Danielides S, Zintzaras E, Vlachoyiannopoulos PG, Moutsopoulos HM.

Lupus. 2009 Oct;18(12):1096-9. doi: 10.1177/0961203309106763.

PMID:
19762385
36.

Recent advances in the treatment of systemic sclerosis.

Bournia VK, Vlachoyiannopoulos PG, Selmi C, Moutsopoulos HM, Gershwin ME.

Clin Rev Allergy Immunol. 2009 Jun;36(2-3):176-200. doi: 10.1007/s12016-008-8114-x. Review.

PMID:
19132559
37.

Comparative qualitative and quantitative analysis of scleroderma (systemic sclerosis) serologic immunoassays.

Picha L, Pakas I, Guialis A, Moutsopoulos HM, Vlachoyiannopoulos PG.

J Autoimmun. 2008 Sep;31(2):166-74. doi: 10.1016/j.jaut.2008.07.001. Epub 2008 Aug 13.

PMID:
18703312
38.

Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.

Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM.

J Rheumatol. 2008 Sep;35(9):1768-75. Epub 2008 Jul 15.

PMID:
18634157
39.

The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.

Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G.

Scand J Rheumatol. 2008 Jul-Aug;37(4):278-83. doi: 10.1080/03009740801978871.

PMID:
18612928
40.

Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease.

Tzelepis GE, Plastiras SC, Karadimitrakis SP, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):734-9.

PMID:
18078622
41.

Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M, Olesinska M, Pokorny G, Rozman B, Schneider M, Vlachoyiannopoulos PG, Swaak A.

Lupus. 2007;16(5):309-17.

PMID:
17576731
42.

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

Vlachoyiannopoulos PG, Samarkos M, Sikara M, Tsiligros P.

Crit Rev Clin Lab Sci. 2007;44(3):271-338. Review.

PMID:
17453920
43.

Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.

Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A.

Autoimmunity. 2007 May;40(3):223-33.

PMID:
17453722
44.

Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients.

Oikonomidou O, Vlachoyiannopoulos PG, Kominakis A, Kalofoutis A, Moutsopoulos HM, Moutsatsou P.

Neuroimmunomodulation. 2006;13(4):194-204. Epub 2007 Mar 7.

PMID:
17347585
45.

Catastrophic antiphospholipid syndrome with heart involvement: diagnostic utility of the cardiac MRI.

Plastiras SC, Tzelepis GE, Kelekis NL, Vlachoyiannopoulos PG.

Int J Cardiol. 2007 Mar 2;116(1):e29-31. Epub 2006 Nov 20. No abstract available.

PMID:
17113663
46.

Mycophenolate mofetil for interstitial lung disease in scleroderma.

Plastiras SC, Vlachoyiannopoulos PG, Tzelepis GE.

Rheumatology (Oxford). 2006 Dec;45(12):1572. Epub 2006 Sep 23. No abstract available.

PMID:
16998235
47.

Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.

Plastiras SC, Karadimitrakis SP, Ziakas PD, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzelepis GE.

Arthritis Rheum. 2006 Aug 15;55(4):598-602.

48.

Pathogenetic potential of antiphospholipid antibodies.

Vlachoyiannopoulos PG, Samarkos M.

Future Cardiol. 2006 May;2(3):303-14. doi: 10.2217/14796678.2.3.303.

PMID:
19804088
49.

Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response.

Routsias JG, Vlachoyiannopoulos PG, Tzioufas AG.

Crit Rev Clin Lab Sci. 2006;43(3):203-48. Review.

PMID:
16574554
50.

Severe gastrointestinal involvement in systemic sclerosis.

Plastiras SC, Tzivras M, Vlachoyiannopoulos PG.

Clin Rheumatol. 2007 Jun;26(6):1025-6. Epub 2006 Mar 21.

PMID:
16550300

Supplemental Content

Loading ...
Support Center